Patents by Inventor Vincent Jannin

Vincent Jannin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition comprising solid dispersion of BCS class II drugs with Gelucires
    Patent number: 10952966
    Abstract: A solid pharmaceutical composition comprising a solid dispersion of a BCS Class II drug in a solid carrier/hydrophilic carrier; and a pH modifier. The solid carrier/hydrophilic carrier has a melting point of between about 40° C. to about 60° C. and an HLB value of between about 10 and about 18. The BCS Class II drug may be telmisartan.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: March 23, 2021
    Assignee: Gattefosse India Pvt. Ltd.
    Inventors: Nabil Farah, Sunil Bambarkar, Vincent Jannin, Chhanda Kapadia, Mangal Nagarsenker, Meenakshi Venkataraman, Megha Marwah
  • Pharmaceutical Composition Comprising Solid Dispersion of BCS Class II Drugs with Gelucires
    Publication number: 20170119671
    Abstract: A solid pharmaceutical composition comprising a solid dispersion of a BCS Class II drug in a solid carrier/hydrophilic carrier; and a pH modifier. The solid carrier/hydrophilic carrier has a melting point of between about 40° C. to about 60° C. and an HLB value of between about 10 and about 18. The BCS Class II drug may be telmisartan.
    Type: Application
    Filed: January 6, 2017
    Publication date: May 4, 2017
    Inventors: Nabil FARAH, Sunil BAMBARKAR, Vincent JANNIN, Chhanda KAPADIA, Mangal NAGARSENKER, Meenakshi VENKATARAMAN, Megha MARWAH
  • CELL CULTURE METHOD AND SYSTEM FOR ESTABLISHING AN IN VITRO MODEL OF THE INTESTINAL BARRIER
    Publication number: 20130302888
    Abstract: Cell culture process includes seeding a suitable culture medium with enterocytes and then, after a delay, seeding the medium containing the enterocytes that have begun to proliferate, with goblet cells.
    Type: Application
    Filed: February 17, 2012
    Publication date: November 14, 2013
    Applicant: GATTEFOSSE SAS
    Inventors: Frederic Demarne, Vincent Jannin, Alf Lamprecht, Yann Pellequer, Arnaud Beduneau
  • Pharmaceutical composition for oral use comprising an active principle liable to undergo a large first intestinal passage effect
    Publication number: 20040146538
    Abstract: Use of an oral pharmaceutical composition to reduce the intestinal passage effect on the active principle contained in, the said composition being in the form of a system which is self-microemulsifying on contact with an aqueous phase, comprising:
    Type: Application
    Filed: January 23, 2004
    Publication date: July 29, 2004
    Applicant: Gattefosse Holding
    Inventors: Hassan Benameur, Vincent Jannin, Delphine Marchaud
  • Method and formulation for decreasing statin metabolism
    Patent number: 6652865
    Abstract: A pharmaceutical composition for oral use is disclosed. It includes, as active principle, a drug liable to undergo a strong first intestinal passage effect and a carrier which is self-micro-emulsifying on contact with an aqueous phase. The carrier includes: a therapeutically effective amount of the active principle; a lipophilic phase, which is a mixture of glycerol mono-, di- and triesters and of PEG mono- and diesters with at least one fatty acid chosen from the group comprising C8-C18 fatty acids; a surfactant phase which is a mixture of glycerol mono-, di- and triesters and of PEG mono- and diesters with caprylic acid (C8) and capric acid (C10); a co-surfactant phase which is an ester of a polyvalent alcohol with at least one fatty acid chosen from the group comprising caprylic esters of propylene glycol, lauric esters of propylene glycol and oleic esters of polyglycerol. A method of decreasing the effect of intestinal metabolism on a drug using the composition is also disclosed.
    Type: Grant
    Filed: August 22, 2001
    Date of Patent: November 25, 2003
    Assignee: Gattefosse Holding
    Inventors: Hassan Benameur, Vincent Jannin, Delphine Roulot
  • Pharmaceutical composition for oral use comprising an active principle to undergo a large first intestinal passage effect
    Publication number: 20030086948
    Abstract: A pharmaceutical composition for oral use is disclosed. It includes, as active principle, a drug liable to undergo a strong first intestinal passage effect and a carrier which is self-micro-emulsifying on contact with an aqueous phase.
    Type: Application
    Filed: August 22, 2001
    Publication date: May 8, 2003
    Applicant: GATTEFOSSE S.A.
    Inventors: Hassan Benameur, Vincent Jannin, Delphine Roulot